These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30041942)

  • 1. Rare cancers: A network for better care.
    Sandrucci S; Gatta G
    Eur J Surg Oncol; 2019 Jan; 45(1):1-2. PubMed ID: 30041942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Care networks in oncology, an evidence for all?].
    Ray-Coquard I; Ducimetière F; Farsi F
    Bull Cancer; 2013; 100(7-8):650-4. PubMed ID: 24063023
    [No Abstract]   [Full Text] [Related]  

  • 3. Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium.
    Stordeur S; Vrijens F; Leroy R
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):1-6. PubMed ID: 26745998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours.
    Laskaratos FM; Caplin M
    Eur J Surg Oncol; 2019 Jan; 45(1):52-59. PubMed ID: 29685756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Towards a better organisation of care for rare diseases in France: a health professional perspective].
    Jondeau G
    Med Sci (Paris); 2018 May; 34 Hors série n°1():11-13. PubMed ID: 29911545
    [No Abstract]   [Full Text] [Related]  

  • 6. [Towards a better organisation of care for rare diseases in France : a ministry perspective].
    Chevrier A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():9-10. PubMed ID: 29911544
    [No Abstract]   [Full Text] [Related]  

  • 7. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.
    Nicolai N; Biasoni D; Catanzaro MA; Colecchia M; Trama A;
    Eur J Surg Oncol; 2019 Jan; 45(1):60-66. PubMed ID: 29526370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quarter of patients with rarer cancers see GPs several times before referral.
    Mayor S
    BMJ; 2016 Feb; 352():i1198. PubMed ID: 26929277
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment challenges in and outside a network setting: Soft tissue sarcomas.
    Pasquali S; Bonvalot S; Tzanis D; Casali PG; Trama A; Gronchi A;
    Eur J Surg Oncol; 2019 Jan; 45(1):31-39. PubMed ID: 28985973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving treatment results with reference centres for rare cancers: where do we stand?
    Ray-Coquard I; Pujade Lauraine E; Le Cesne A; Pautier P; Vacher Lavenue MC; Trama A; Casali P; Coindre JM; Blay JY
    Eur J Cancer; 2017 May; 77():90-98. PubMed ID: 28384534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized teams or specialist networks for rare cancers?
    Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG
    Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment challenges in and outside a network setting: Head and neck cancers.
    Orlandi E; Alfieri S; Simon C; Trama A; Licitra L;
    Eur J Surg Oncol; 2019 Jan; 45(1):40-45. PubMed ID: 29478741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
    Printz C
    Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rare tumors: the need for special centers].
    Massard C
    Bull Cancer; 2014 Feb; 101(2):115. PubMed ID: 25813683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Together for patients with hereditary neuromuscular conditions].
    Arntzen KA; Lund I; Rasmussen M; Rønningen KE; Torp TI; Ørstavik K
    Tidsskr Nor Laegeforen; 2016 Aug; 136(14-15):1198-9. PubMed ID: 27554555
    [No Abstract]   [Full Text] [Related]  

  • 17. Focus on designing health care structures and services for rare diseases.
    Schultz C; Schreyögg J; Stargardt T; Busse R
    Health Policy; 2012 May; 105(2-3):107-9. PubMed ID: 22469233
    [No Abstract]   [Full Text] [Related]  

  • 18. [Orphan diseases: what are the roles for associations? ].
    Araiedh J; Badoux T; Berweiler A; Egli L; Gartmann M
    Rev Med Suisse; 2013 Jul; 9(393):1435-6. PubMed ID: 23971330
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rare tumors: limits of expertise and external consultation].
    Glehen O; Gilly FN
    Ann Pathol; 2014 Feb; 34(1):2-3. PubMed ID: 24630630
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.
    Lykoudis PM; Partelli S; Muffatti F; Caplin M; Falconi M; Fusai GK;
    Eur J Surg Oncol; 2019 Jan; 45(1):46-51. PubMed ID: 29126671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.